Panoramica dell'azienda
Ping An Biomedical Co., Ltd. operates primarily as a provider of supply chain management services within the apparel industry, with a geographic footprint spanning China, Hong Kong, Cambodia, and Europe. The enterprise focuses on delivering a comprehensive suite of operational capabilities, including market trend analysis, product design and development, raw material sourcing, production oversight, and quality control. This business model positions the company within the Consumer Cyclical sector, specifically under the Textile Manufacturing industry, where its activities are intrinsically linked to consumer spending patterns and global fashion cycles. The company currently maintains a market capitalization of $18.81M and reported annual revenue of $34.15M over the trailing twelve months, employing a workforce of 7 individuals. These financial metrics indicate that the firm operates on a very small scale relative to its peers, suggesting a niche position or a highly specialized operational focus rather than broad market dominance. The low employee count coupled with the specific revenue figure implies a lean organizational structure, yet the valuation suggests the market prices the stock based on future potential rather than current earnings power.
Salute finanziaria
The company generated revenue of $34.15M in the trailing twelve months, yet reported a net income of $-12,829,206 and an EBITDA of $-14,695,886, revealing a severe disconnect between top-line sales and bottom-line profitability. The substantial gap between the $34.15M revenue and the negative net income indicates that the cost structure is heavily burdened by expenses that exceed gross revenues, resulting in an inability to retain earnings from operations. Furthermore, the free cash flow stands at $-59,241,688, which signifies a significant outflow of cash from the business and a lack of financial flexibility to fund operations without external capital injections. Profitability is further eroded by a gross margin of 2.8%, an operating margin of -69.6%, and a profit margin of -37.6%, all of which indicate that the company is losing money on nearly every dollar of revenue generated. On the balance sheet, the firm holds $1.17M in cash against $10.47M in debt, resulting in a debt-to-equity ratio of 23.14, which characterizes the balance sheet as highly leveraged and reliant on external financing to meet obligations. Despite the leverage, the current ratio is reported at 2.76, suggesting that the company technically maintains sufficient current assets to cover its short-term liabilities, although the quality of those assets may be compromised by the negative cash flow environment. Return on Equity is -67.4% and Return on Assets is -14.7%, metrics that reveal management is currently destroying shareholder value and failing to generate returns on the capital deployed.
Valutazione del valore
Both the P/E Ratio (TTM) and Forward P/E are listed as N/A, which implies that traditional earnings-based valuation multiples cannot be applied due to the company's consistent lack of positive net income over the trailing period. The price-to-book ratio stands at 0.47, indicating that the market values the company at less than half of its book value, a scenario often seen in distressed or unprofitable firms where assets are undervalued or liabilities are understated. Alternative valuation metrics provide further insight, with a price-to-sales ratio of 0.55 and an EV/EBITDA of -0.89, suggesting that the market is pricing the stock based on revenue multiples rather than earnings potential, likely anticipating a turnaround or relying on asset value. Regarding trading range, the 52-week high is $5.40 and the 52-week low is $0.12; given the negative earnings and cash flow, the current valuation sits in a context where price discovery is driven by liquidity events rather than fundamental growth. The beta value is listed as N/A, meaning that the historical volatility data required to calculate this metric is unavailable, preventing a direct comparison of the stock's price volatility relative to the broader market.
Growth & Income
Revenue growth over the last year is -62.0%, while earnings growth is N/A due to the absence of positive earnings in the prior period, indicating a significant contraction in business activity or a sharp decline in demand for apparel supply chain services. Since earnings are negative, the comparison of earnings growth versus revenue growth is not mathematically possible, but the negative revenue growth rate suggests the company is shrinking in scale or losing market share within its specific niche. As a non-dividend payer, the company does not distribute cash to shareholders, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning that any available cash flow is theoretically reinvested or retained, though the negative free cash flow limits actual reinvestment capacity. The overall growth and income profile is characterized by negative revenue expansion and a complete absence of dividend income, reflecting a company in a phase of significant financial distress rather than stable growth or income generation.